Anshuman Sakle is a partner in the competition law practice at Cyril Amarchand Mangaldas. He advises clients on all issues related to market practice, as well as market structure, including merger control, abuse of dominance and cartel enforcement. He advises on compliance aspects related to the enforcement provisions of Indian competition law and has conducted mock ‘dawn raids’ and competition audits. Further, Anshuman has been involved in the drafting and filing of leniency applications with the Competition Commission of India (CCI).
Anshuman has advised clients across various sectors such as pharmaceuticals, automotive components, media and entertainment, financial services, heavy machinery, civil aviation, chemicals and information technology. He has assisted in obtaining merger control approvals for several marquee transactions including Sun Pharma/Ranbaxy (the first Phase II investigation in India which lead to structural modifications), Orchid/Hospira (the first matter in which parties made modifications to the terms of their agreement to secure the approval of the CCI), Grasim/Aditya Birla Chemicals, ZF Friedrichshafen/TRW Automotive, Reliance Communications/Sistema Shyam and Temasek/Intas.
Anshuman has been a resource person on merger control and abuse of dominance modules for the certificate courses provided by the Indian Institute of Corporate Affairs. His articles have been published by the Financial Express, International Bar Association, Businessworld, Practical Lawyer, India Business Law Journal, Manupatra Competition Law Reports and Money Control (CNBC-TV18). He has also co-authored the India chapters in the Cartels & Leniency Guide 2015 (International Comparative Legal Guides) and The Public Competition Enforcement Review (Seventh Edition) (Law Business Research). He recently co-authored the module on abuse of dominance in Lexis Nexis’ Practical Guidance. Anshuman has been recognised for his experience in publications such as Chambers and Partners.